Axsome Therapeutics Earns Relative Strength Rating Upgrade; Hits Key Threshold
Learn about finding top growth stocks with the IBD Screen of the Day, focusing on Relative Strength (RS) Ratings. Stocks with an RS Rating of at least 80 tend to make significant gains. Axsome Therapeutics is a stock to watch with a cup-with-handle pattern and upcoming earnings report.